Parallel Bio is building a human-first drug discovery platform that combines organoids and AI to conduct experiments using human biology. The company reports that its platform is 87% concordant with clinical patient data and has demonstrated models of immunotoxicology, immunogen stimulation, and two autoimmune diseases. Pharma partners, including three Fortune 500 companies, are using the platform. The company has raised approximately $30 million from AIX Ventures, Marc Benioff, Jeff Dean, and Y Combinator. The role is at Staff level or higher and focuses on full-stack AI, including evaluations, agents, and models.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
No Education Listed